Vis enkel innførsel

dc.contributor.authorUhlig, Benjamin Langsæter
dc.contributor.authorSand, Trond
dc.contributor.authorNilsen, Tom Ivar Lund
dc.contributor.authorMork, Paul Jarle
dc.contributor.authorHagen, Knut
dc.date.accessioned2018-09-04T12:44:09Z
dc.date.available2018-09-04T12:44:09Z
dc.date.created2018-04-30T08:17:12Z
dc.date.issued2018
dc.identifier.citationBMC Musculoskeletal Disorders. 2018, 19:128 1-9.nb_NO
dc.identifier.issn1471-2474
dc.identifier.urihttp://hdl.handle.net/11250/2560749
dc.description.abstractBackground The aim of this study was to investigate the prospective association between insomnia and risk of chronic musculoskeletal complaints (CMSC) and chronic widespread musculoskeletal complaints (CWMSC). A second aim was to evaluate the association between insomnia and number of body regions with CMSC at follow-up. Methods We used data from the second (HUNT2, 1995–1997) and third (HUNT3, 2006–2008) wave of the Nord-Trøndelag Health Study (the HUNT Study). The population-at-risk included 13,429 people aged 20–70 years who reported no CMSC at baseline in HUNT2 and who answered the questionnaires on insomnia in HUNT2 and CMSC in HUNT3. Insomnia was defined according to the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) with minor modification, whereas CMSC was assessed for nine different body regions. CWMSC was defined according to the 1990 criteria by the American College of Rheumatology. We used Poisson regression to estimate adjusted risk ratios (RRs) for CMSC and CWMSC at 11 years follow-up. Precision of the estimates was assessed by a 95% confidence interval (CIs). Results Insomnia at baseline was associated with increased risk of any CMSC (RR 1.16, 95% CI 1.03–1.32) and CWMSC (RR 1.58, 95% CI 1.26–1.98) at follow-up. RR for CMSC for specific body regions ranged from 1.34 (95% CI 1.05–1.73) for the knees and 1.34 (1.10–1.63) for the neck to 1.60 (95% CI 1.19–2.14) for the ankles/ft. Further, insomnia was associated with increased risk of CMSC in 3–4 regions (RR 1.36, 95% CI 1.05–1.77), and 5 or more regions (RR 1.93, 95% CI 1.40–2.66), but not 1–2 regions (RR 0.99, 95% CI 0.80–1.24). Conclusions Insomnia is associated with increased risk of CMSC, CWMSC, and CMSC located in 3 or more body regions.nb_NO
dc.language.isoengnb_NO
dc.publisherBMC (part of Springer Nature)nb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleInsomnia and risk of chronic musculoskeletal complaints: longitudinal data from the HUNT study, Norwaynb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber1-9nb_NO
dc.source.volume19nb_NO
dc.source.journalBMC Musculoskeletal Disordersnb_NO
dc.source.issue128nb_NO
dc.identifier.doi10.1186/s12891-018-2035-5
dc.identifier.cristin1582394
dc.description.localcode© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)nb_NO
cristin.unitcode194,65,30,0
cristin.unitcode194,65,20,0
cristin.unitnameInstitutt for nevromedisin og bevegelsesvitenskap
cristin.unitnameInstitutt for samfunnsmedisin og sykepleie
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal